Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights from the ASPIRE Study. Esquenazi A, Francisco GE, Feng W, Baricich A, et al. Arch Phys Med Rehabil 2021 Jul 7. pii: S0003-9993(21)00497.

Read + Share

Amedeo Smart

Independent Medical Education

Esquenazi A, Francisco GE, Feng W, Baricich A, et al. Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights from the ASPIRE Study. Arch Phys Med Rehabil 2021 Jul 7. pii: S0003-9993(21)00497.
PMID: 34245684